The lede: Investors screening for "defense" exposure look for missiles, satellites, and radar. They miss Axon (AXON) — because Axon's ticker sits under "law enforcement gear," not "national security." That's the mispricing. ICE posted a request in late February for a five-year, roughly $220 million Taser contract covering about 17,800 units — nearly quadrupling its current ~4,300-unit inventory — with specs (45-foot range, ten individually targeted probes) that procurement reviewers say only Axon's Taser 10 meets. Layer that onto an existing DHS body-camera and digital-evidence contract with a ceiling near $370 million (only ~$67.5 million obligated so far, meaning most of it hasn't even been drawn down yet), and you have a company whose growth is gated less by consumer demand than by appropriations riders, DHS/ICE budget expansion, and executive-branch procurement priorities. Axon spent nearly $2.5 million on lobbying in 2025 — its highest total ever — aimed squarely at body-camera mandates and federal digital-evidence rules. That's not a police-supply company. That's a homeland-security policy stock.
Who cashes in: